Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 1061-1066
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1061
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1061
Table 2 Types of proton pump inhibitors used in the pretreatment in Group B n (%)
| Group B-I3-14 d (n = 146) | Group B-II15-55 d (n = 274) | Group B-III≥56 d (n = 97) | P value1 | |
| Lansoprazole | 80 (54.8) | 174 (63.5) | 62 (63.9) | 0.294 |
| Rabeprazole | 56 (38.4) | 82 (29.9) | 29 (29.9) | |
| Esomeprazole | 8 (5.5) | 17 (6.2) | 4 (4.1) | |
| Omeprazole | 2 (1.4) | 1 (0.4) | 2 (2.1) |
-
Citation: Yoon SB, Park JM, Lee JY, Baeg MK, Lim CH, Kim JS, Cho YK, Lee IS, Kim SW, Choi MG. Long-term pretreatment with proton pump inhibitor and
Helicobacter pylori eradication rates. World J Gastroenterol 2014; 20(4): 1061-1066 - URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1061.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.1061